002919.SZ
名臣健康
SZSE · Consumer Defensive · I 信息技术 · CN
CNY 16.92
−2.20%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.6B | 1.5B | 1.4B | 1.6B | 945.4M |
| Cost of Revenue | 706.2M | 694.8M | 655.6M | 650.7M | 449.1M |
| Gross Profit | 864.4M | 819.6M | 724.6M | 986.9M | 496.3M |
| Operating Expenses | |||||
| R&D Expense | 59.0M | 57.6M | 69.4M | 111.3M | 110.3M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 97.2M | 95.7M | 106.0M | 110.0M | 82.4M |
| Selling & Marketing Expense | 699.3M | 641.2M | 443.6M | 664.7M | 321.0M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 863.3M | 800.9M | 624.3M | 892.0M | 514.3M |
| Cost and Expenses | 1.6B | 1.5B | 1.3B | 1.5B | 963.3M |
| Operating Income (EBIT) | 44.7M | 54.7M | 31.3M | 57.9M | (5.5M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 43.3M | 53.6M | 27.5M | 56.6M | 15.2M |
| Income Tax Expense | 20.0M | 25.8M | (19.2M) | (13.7M) | (10.1M) |
| Bottom Line | |||||
| Net Income | 24.8M | 28.3M | 46.7M | 70.4M | 25.4M |
| Earnings from Cont. Ops | 23.3M | 27.8M | 46.7M | 70.4M | 25.4M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 24.8M | 28.3M | 46.7M | 70.4M | 25.4M |
| Per Share | |||||
| Basic EPS | CN¥0.09 | CN¥0.11 | CN¥0.18 | CN¥0.26 | CN¥0.11 |
| Diluted EPS | CN¥0.09 | CN¥0.11 | CN¥0.18 | CN¥0.26 | CN¥0.11 |
| Revenue Per Share | CN¥5.89 | CN¥5.68 | CN¥5.18 | CN¥6.05 | CN¥4.10 |
| Shares | |||||
| Basic Shares Outstanding | 266.6M | 266.6M | 266.5M | 270.6M | 230.8M |
| Diluted Shares Outstanding | 266.6M | 266.6M | 266.5M | 270.6M | 230.8M |
| Profitability Metrics | |||||
| EBITDA | — | 79.1M | 70.1M | 215.5M | 40.2M |
| D&A | — | 24.4M | 38.8M | 157.5M | 45.7M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026